Valeo Financial Advisors LLC Purchases New Position in Cardinal Health, Inc. $CAH

Key Points

• Valeo Financial Advisors LLC acquired a new stake in Cardinal Health, purchasing 2,528 shares valued at approximately $425,000 in the second quarter.
• Insider sales included CEO Jason M. Hollar and Ola M. Snow, who sold a combined total of over $20 million worth of shares, indicating a significant reduction in their ownership.
• Cardinal Health announced a quarterly dividend of $0.5107, which will be distributed on October 15th, yielding about 1.3% annually.

Valeo Financial Advisors LLC purchased a new stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 2,528 shares of the company's stock, valued at approximately $425,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. DAVENPORT & Co LLC increased its stake in shares of Cardinal Health by 28.7% in the 2nd quarter. DAVENPORT & Co LLC now owns 8,592 shares of the company's stock valued at $1,443,000 after purchasing an additional 1,918 shares in the last quarter. JSF Financial LLC increased its stake in shares of Cardinal Health by 4.4% in the 2nd quarter. JSF Financial LLC now owns 9,448 shares of the company's stock valued at $1,587,000 after purchasing an additional 397 shares in the last quarter. IFS Advisors LLC increased its stake in shares of Cardinal Health by 23.4% in the 2nd quarter. IFS Advisors LLC now owns 1,280 shares of the company's stock valued at $215,000 after purchasing an additional 243 shares in the last quarter. Simplicity Wealth LLC purchased a new position in shares of Cardinal Health in the 2nd quarter valued at about $425,000. Finally, Highland Capital Management LLC purchased a new position in shares of Cardinal Health in the 2nd quarter valued at about $1,582,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Insider Transactions at Cardinal Health

In related news, insider Ola M. Snow sold 28,151 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the transaction, the insider directly owned 15,431 shares in the company, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Jason M. Hollar sold 107,705 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total value of $16,037,274.50. Following the completion of the transaction, the chief executive officer owned 235,901 shares in the company, valued at $35,125,658.90. This represents a 31.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 271,676 shares of company stock valued at $40,489,525 in the last ninety days. 0.12% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on CAH. Wells Fargo & Company restated an "overweight" rating and issued a $185.00 price target (up previously from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Weiss Ratings reiterated a "buy (b)" rating on shares of Cardinal Health in a research note on Wednesday. Argus set a $189.00 price objective on Cardinal Health in a research note on Friday, August 22nd. UBS Group reiterated a "buy" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Finally, Morgan Stanley reiterated an "overweight" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $166.00.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $157.24 on Friday. The stock has a market cap of $37.36 billion, a P/E ratio of 24.38, a P/E/G ratio of 1.33 and a beta of 0.71. The stock's 50 day simple moving average is $152.07 and its 200-day simple moving average is $150.92. Cardinal Health, Inc. has a 1-year low of $106.98 and a 1-year high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $2.03 by $0.05. The business had revenue of $60.16 billion for the quarter, compared to analysts' expectations of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business's revenue for the quarter was up .5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, research analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. Cardinal Health's dividend payout ratio is currently 31.63%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.